Perrigo (PRGO) Enterprise Value (2012 - 2026)
Perrigo (PRGO) posted quarterly Enterprise Value of -$357.2 million for Q1 2026, up 12.86% year-over-year from -$316.5 million in Q1 2025, and up 32.81% quarter-over-quarter from -$531.6 million in Q4 2025.
Perrigo (PRGO) Enterprise Value (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Enterprise Value for 15 consecutive years, with -$357.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 12.86% year-over-year to -$357.2 million; the TTM figure through Mar 2026 stood at -$357.2 million (up 12.86% YoY), while the FY2025 annual figure was -$531.6 million, up 4.87% from the prior year.
- Enterprise Value climbed to -$357.2 million in Q1 2026 per PRGO's latest filing, from -$531.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$357.2 million in Q1 2026 and bottomed at -$2.0 billion in Q2 2022.
- Historically, Enterprise Value has averaged -$669.8 million across 5 years, with a median of -$553.0 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 77.45% in 2022 and fell as far as 317.39% in 2022.
- Perrigo's Enterprise Value stood at -$600.7 million in 2022, then dropped by 25.07% to -$751.3 million in 2023, then climbed by 25.62% to -$558.8 million in 2024, then increased by 4.87% to -$531.6 million in 2025, then surged by 32.81% to -$357.2 million in 2026.
- Business Quant data shows PRGO's Enterprise Value at -$357.2 million in Q1 2026, -$531.6 million in Q4 2025, and -$432.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | -399.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -399.70 Mn |
| Mar 28, 2026 | -357.20 Mn |
| Dec 31, 2025 | -531.60 Mn |
| Sep 27, 2025 | -432.10 Mn |
| Jun 28, 2025 | -454.20 Mn |
| Mar 29, 2025 | -409.90 Mn |
| Dec 31, 2024 | -558.80 Mn |
| Sep 28, 2024 | -1.46 Bn |
| Jun 29, 2024 | -542.80 Mn |
| Mar 30, 2024 | -658.50 Mn |
| Dec 31, 2023 | -751.30 Mn |
| Sep 30, 2023 | -598.30 Mn |
| Jul 1, 2023 | -555.20 Mn |
| Apr 1, 2023 | -553.00 Mn |
| Dec 31, 2022 | -600.70 Mn |
| Oct 1, 2022 | -468.70 Mn |
| Jul 2, 2022 | -485.30 Mn |
| Apr 2, 2022 | -1.97 Bn |
| Dec 31, 2021 | -1.86 Bn |
| Oct 2, 2021 | -2.08 Bn |